Killeen TX 结直肠癌临床试验
6项针对 结直肠癌的研究正在 Killeen及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Baylor Scott & White Medical Center-Temple, Temple · 距离 23 英里
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
招募中3 期
- Scott And White Memorial Hospital, Temple · 距离 23 英里
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
招募中3 期
- Baylor Scott and White Health, Temple · 距离 23 英里
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- Baylor Scott & White Health, Temple · 距离 23 英里
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
招募中2 期
- Baylor Scott & White Medical Center, Temple · 距离 23 英里
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
招募中观察性研究
- Baylor Scott and White Biorepository, Temple · 距离 23 英里
其他城市的 结直肠癌试验
- Houston, TX102 项研究
- New York City, NY78 项研究
- Nashville, TN69 项研究
- Boston, MA63 项研究
- Los Angeles, CA59 项研究
- Arlington, VA52 项研究
- St. Louis, MO50 项研究
- San Antonio, TX46 项研究
- Philadelphia, PA44 项研究
- Grand Rapids, MI40 项研究
- Baldwin Park, CA37 项研究
- Chicago, IL34 项研究
Killeen的其他研究
- 创伤后应激障碍8 项研究
- 心力衰竭6 项研究
- 癌症（所有类型）5 项研究
- 结肠癌5 项研究
- 膀胱癌5 项研究
- 2型糖尿病4 项研究
- 转移性癌症4 项研究
- 乳腺癌4 项研究
- 非小细胞肺癌4 项研究
- 卵巢癌4 项研究
- 子宫内膜癌4 项研究
- 伯基特淋巴瘤3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。